Streetbeat News

Analyst Ratings

NEOG

Neogen (NASDAQ:NEOG) is set to release its quarterly earnings report on October 10, 2024, with analysts estimating an EPS of $0.08. The company's past performance has shown a tendency to miss estimates, impacting stock prices negatively. Neogen's stock is currently trading at $14.69, with a 52-week decline of 2.27%. Analysts have given Neogen a Neutral rating with a price target of $17.5, suggesting a potential upside. Compared to peers like Haemonetics, UFP Techs, and ICU Medical, Neogen ranks lower in revenue growth, gross profit, and return on equity.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:00 pm

RNR

RenaissanceRe Holdings (NYSE:RNR) has received mixed analyst ratings over the past three months, with a recent average price target of $272.2, reflecting a 5.4% increase. Analysts have adjusted their ratings and price targets, indicating varied expectations for the company's performance. RenaissanceRe has shown strong financial performance with significant revenue growth, high net margins, and efficient asset use.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:00 pm

DAL

Delta Air Lines is set to release its quarterly earnings on October 10, 2024, with analysts expecting an EPS of $1.55. The company's past performance shows mixed results, with a recent EPS miss leading to a share price drop. Analysts have a 'Buy' rating on Delta, with a price target suggesting a 21.49% upside. Delta's financial metrics show strong revenue growth and profitability, but it ranks lower in gross profit compared to peers.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:00 pm

SEIC

SEI Investments (NASDAQ:SEIC) has been evaluated by 4 analysts over the past three months, with ratings ranging from somewhat bullish to indifferent. The average 12-month price target has increased slightly to $74.75. Analysts have adjusted their ratings and price targets, reflecting their perceptions of SEI Inv's market position. The company has shown notable revenue growth but faces challenges with net margin and market capitalization.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:00 pm

FOUR

Shift4 Payments (NYSE:FOUR) has received diverse analyst ratings over the past three months, with a mix of bullish and somewhat bullish outlooks. Analysts have set a 12-month average price target of $98.11, up from $88.86 previously. The company has shown strong revenue growth but faces challenges with profitability and financial risk due to high debt levels.

Portfolio Pulse from Benzinga Insights

October 09, 2024 | 2:00 pm

SAGE

Wedbush analyst Laura Chico maintains a Neutral rating on Sage Therapeutics and lowers the price target from $9 to $8.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:57 pm

META

BMO Capital analyst Brian Pitz maintains a Market Perform rating on Meta Platforms and raises the price target from $475 to $525.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:56 pm

FDX

Citigroup has initiated coverage on FedEx with a Buy rating and set a price target of $301, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:53 pm

TVTX

Wedbush analyst Laura Chico maintains an Outperform rating on Travere Therapeutics and raises the price target from $17 to $25.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:53 pm

RNR

Evercore ISI Group has maintained an 'Underperform' rating on RenaissanceRe Holdings while raising the price target from $218 to $229.

Portfolio Pulse from Benzinga Newsdesk

October 09, 2024 | 1:53 pm